William A. Hawkins III - 14 Mar 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
Director
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
14 Mar 2022
Net transactions value
$0
Form type
4
Filing time
16 Mar 2023, 21:19:58 UTC
Previous filing
15 Feb 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +3,949 +4.3% 96,310 14 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +3,949 $0.000000 3,949 14 Mar 2022 Class A Common Stock 3,949 Direct F1, F2
transaction BVS Restricted Stock Units Options Exercise $0 -3,949 -100% $0.000000* 0 14 Mar 2023 Class A Common Stock 3,949 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs vest in full on March 14, 2023.